US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

0.7798

+0.01281.67%

Post-market: 0.7700-0.0098-1.26%19:21 EDT

Volume:804.65K

Turnover:613.83K

Market Cap:126.13M

PE:-0.51

High:0.7798

Open:0.7630

Low:0.7315

Close:0.7670

Loading ...

Overview Company News Filings

Positive Outlook for Neumora Therapeutics Amid Key Milestones and Competitive Edge

J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital

Positive Outlook on Neumora Therapeutics Driven by Navacaprant’s Potential in MDD Treatment

Analysts’ Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)

This biotech's stock could double if its treatment for major depressive disorder succeeds, says Mizuho

RBC Capital Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics Reports Q3 2024 Financial Results

Neumora Therapeutics Q3 Loss Narrows

MT Newswires Live

Press Release: Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Mizuho Securities Remains a Buy on Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics to Participate in Upcoming Conferences in November

Neumora Therapeutics Cut to Neutral From Overweight by JP Morgan

Neumora Therapeutics downgraded to Neutral from Overweight at JPMorgan

Neumora Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS

LIVE MARKETS-Brainy efforts underway, but still some way to go for neuro drug developers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NMRA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":0.7798,"timestamp":1746043200000,"preClose":0.767,"halted":0,"volume":804653,"hourTrading":{"tag":"盘后","latestPrice":0.77,"preClose":0.7798,"latestTime":"19:21 EDT","volume":2615,"amount":2034.6734,"timestamp":1746055289688},"delay":0,"floatShares":53359830,"shares":161747922,"eps":-1.529624,"marketStatus":"Not Yet Opened","change":0.0128,"latestTime":"04-30 16:00:00 EDT","open":0.763,"high":0.7798,"low":0.7315,"amount":613825.8396462,"amplitude":0.062973,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.529624,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746086400000},"marketStatusCode":0,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":0.767,"preHourTrading":{"tag":"盘前","latestPrice":0.7849,"preClose":0.767,"latestTime":"08:08 EDT","volume":3,"amount":2.3697,"timestamp":1746014886423},"postHourTrading":{"tag":"盘后","latestPrice":0.77,"preClose":0.7798,"latestTime":"19:21 EDT","volume":2615,"amount":2034.6734,"timestamp":1746055289688},"volumeRatio":0.8030364874143188,"impliedVol":0.8389,"impliedVolPercentile":0.3494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":53359830,"roa":"-40.50%","roe":"-64.48%","lyrEps":-1.529624,"volumeRatio":0.8030364874143188,"shares":161747922,"dividePrice":0,"high":0.7798,"amplitude":0.062973,"preClose":0.767,"low":0.7315,"week52Low":0.6211,"pbRate":"0.44","week52High":17.1874,"institutionHeld":0,"latestPrice":0.7798,"eps":-1.529624,"divideRate":0,"volume":804653,"delay":0,"ttmEps":-1.529624,"open":0.763,"prevYearClose":10.6,"prevWeekClose":0.7575,"prevMonthClose":1,"prevQuarterClose":1,"fiveDayClose":0.7109,"twentyDayClose":0.9133,"sixtyDayClose":1.86,"earningDate":1746979200000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2491611286","title":"Positive Outlook for Neumora Therapeutics Amid Key Milestones and Competitive Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=2491611286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491611286?lang=en_us&edition=fundamental","pubTime":"2024-12-16 19:36","pubTimestamp":1734348985,"startTime":"0","endTime":"0","summary":"Analyst Douglas Tsao of H.C. Wainwright reiterated a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report), retaining the price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-outlook-for-neumora-therapeutics-amid-key-milestones-and-competitive-edge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-outlook-for-neumora-therapeutics-amid-key-milestones-and-competitive-edge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NMRA","BK4007","LENZ"],"gpt_icon":0},{"id":"2489268188","title":"J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2489268188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489268188?lang=en_us&edition=fundamental","pubTime":"2024-12-07 03:30","pubTimestamp":1733513419,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams notes that the clinicaltrials.gov listing for Johnson & Johnson’s (JNJ) second MDD Phase 3 trial with aticaprant...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jj-trial-news-may-have-positive-read-for-neumora-therapeutics-says-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jj-trial-news-may-have-positive-read-for-neumora-therapeutics-says-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673691.USD","IE00B19Z3B42.SGD","BK4581","LU1162221912.USD","IE00B3PB1722.GBP","LU0912757837.SGD","JNJ","LU2133065610.SGD","ABVC","IE00BJT1NW94.SGD","LU0058720904.USD","NMRA","IE00BDGV0183.EUR","BK4559","LU1032955483.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU1674673428.USD","SG9999002232.USD","BK4585","LU0795875169.SGD","IE0002141913.USD","LU0098860793.USD","LU1066051811.HKD","IE00BGHQF631.EUR","IE00BSNM7G36.USD","LU1244550577.SGD","LU1506573853.SGD","LU1718418525.SGD","LU1914381329.SGD","BK4592","BK4533","LU1244550221.USD","LENZ","LU0345769631.USD","IE00BVYPNV92.GBP","IE00BJJMRZ35.SGD","LU1267930813.SGD","LU0203347892.USD","LU1244550494.USD","LU1585245621.USD","LU0345769128.USD","LU0122379950.USD","LU1023059063.AUD","LU0792757196.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1935042991.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2486796667","title":"Positive Outlook on Neumora Therapeutics Driven by Navacaprant’s Potential in MDD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2486796667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486796667?lang=en_us&edition=fundamental","pubTime":"2024-11-25 15:35","pubTimestamp":1732520139,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh has reiterated their bullish stance on NMRA stock, giving a Buy rating on November 22. Graig Suvannavej...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-outlook-on-neumora-therapeutics-driven-by-navacaprants-potential-in-mdd-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-outlook-on-neumora-therapeutics-driven-by-navacaprants-potential-in-mdd-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","NMRA","ABVC","BK4139"],"gpt_icon":0},{"id":"2485251842","title":"Analysts’ Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485251842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485251842?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:51","pubTimestamp":1732276306,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neumora Therapeutics, Inc. (NMRA – Research Report),...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neumora-therapeutics-inc-nmra-tourmaline-bio-trml?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-neumora-therapeutics-inc-nmra-tourmaline-bio-trml?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","BK4139","NMRA","BK4007","TRML"],"gpt_icon":0},{"id":"2483833259","title":"This biotech's stock could double if its treatment for major depressive disorder succeeds, says Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483833259?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:03","pubTimestamp":1731513780,"startTime":"0","endTime":"0","summary":"It's been 30 years since a novel mechanism of action was approved for the debilitating illness. Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for major depressive disorder, or MDD, later this year.Watertown, Mass.-based Neumora , a clinical-stage biotech that went public in September of 2023, specializes in treatments for central nervous system diseases. Its pipeline includes treatments for bipolar depression, agitation in Alzheimer's disease, schizophrenia and Parkinson's disease.The company's lead product candidate, navacaprant, aims to treat MDD, the leading cause of disability worldwide, according to research conducted by L.E.K. Consulting.An estimated 280 million people around the world suffer from MDD, 21 million of whom are resident in the U.S. It's been 30 years since a novel mechanism of action was approved, creating a high unmet nee","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4139","ABVC","BK4007","MFG","BK4207"],"gpt_icon":0},{"id":"2483059180","title":"RBC Capital Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483059180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483059180?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:58","pubTimestamp":1731499101,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report), wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"gpt_icon":0},{"id":"2483043307","title":"Neumora Therapeutics Reports Q3 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483043307","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483043307?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:52","pubTimestamp":1731473561,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. ( ($NMRA) ) has released its Q3 earnings. Here is a breakdown of the information Neumora Therapeutics, Inc. presented to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","NMRA","BK4007"],"gpt_icon":0},{"id":"2482705059","title":"Neumora Therapeutics Q3 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2482705059","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482705059?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:31","pubTimestamp":1731414706,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics  reported a Q3 loss Tuesday of $0.45 per diluted share, narrower than the loss of $1.14 a year earlier.Analysts polled by Capital IQ expected a loss of $0.39.The clinical-stage biopharmaceutical company did not report any revenue for the quarter ended Sept. 30.Neumora said it had $341.3 million in cash, cash equivalents and marketable securities at the end of the quarter, which it said would enable it to fund its operating plan into mid-2026.Price: 13.58, Change: +0.04, Percent Change: +0.30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","BK4007","NMRA"],"gpt_icon":0},{"id":"2482570815","title":"Press Release: Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2482570815","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482570815?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:00","pubTimestamp":1731412800,"startTime":"0","endTime":"0","summary":"Phase 3 data from KOASTAL-1 study of navacaprant in MDD expected around the end of 2024; KOASTAL-2 and KOASTAL-3 topline data expected in the first half of 2025. Ongoing clinical studies evaluating navacaprant in bipolar depression and NMRA-511 in Alzheimer's disease agitation with data expected in second half of 2025. Clinical study for next M4 PAM program expected to commence clinical in the first half of 2025. Strong financial position with $341.3 million in cash, cash equivalents and marketable securities now expected to support operations into mid-2026. Navacaprant  is a highly selective, novel, once-daily kappa opioid receptor  antagonist being developed as a potential monotherapy treatment for MD","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAM","BK4563","ABVC","KOR","BK4139","LENZ","NMRA","BK4007","BK4081","BK4017"],"gpt_icon":0},{"id":"2482726939","title":"Mizuho Securities Remains a Buy on Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482726939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482726939?lang=en_us&edition=fundamental","pubTime":"2024-11-12 15:48","pubTimestamp":1731397727,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report) yesterday. The company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-buy-on-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-buy-on-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","MFG","NMRA","BK4007"],"gpt_icon":0},{"id":"2481704670","title":"Neumora Therapeutics to Participate in Upcoming Conferences in November","url":"https://stock-news.laohu8.com/highlight/detail?id=2481704670","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481704670?lang=en_us&edition=fundamental","pubTime":"2024-11-06 20:00","pubTimestamp":1730894400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Nov.  06, 2024  (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/06/2975559/0/en/Neumora-Therapeutics-to-Participate-in-Upcoming-Conferences-in-November.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","NMRA"],"gpt_icon":0},{"id":"2481665508","title":"Neumora Therapeutics Cut to Neutral From Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2481665508","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481665508?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:25","pubTimestamp":1730809500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 05, 2024 07:25 ET (12:25 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2481520578","title":"Neumora Therapeutics downgraded to Neutral from Overweight at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2481520578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481520578?lang=en_us&edition=fundamental","pubTime":"2024-11-05 17:55","pubTimestamp":1730800507,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Tessa Romero downgraded Neumora Therapeutics (NMRA) to Neutral from Overweight with a price target of $15, down from $18. Results ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-neutral-from-overweight-at-jpmorgan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-neutral-from-overweight-at-jpmorgan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2481517387","title":"Neumora Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2481517387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481517387?lang=en_us&edition=fundamental","pubTime":"2024-11-05 13:22","pubTimestamp":1730784128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241105:nFWN3MB1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"gpt_icon":0},{"id":"2480483964","title":"LIVE MARKETS-Brainy efforts underway, but still some way to go for neuro drug developers","url":"https://stock-news.laohu8.com/highlight/detail?id=2480483964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480483964?lang=en_us&edition=fundamental","pubTime":"2024-11-01 23:38","pubTimestamp":1730475531,"startTime":"0","endTime":"0","summary":"- CLICK HEREU.S. STOCKS RISE AFTER PAYROLLS AS AMAZON LEADS - CLICK HEREU.S. STOCK FUTURES ADD SLIGHTLY TO GAINS, YIELDS FALL, AFTER JOBS DISAPPOINT -  CLICK HERECOULD OCTOBER PAYROLLS BE NEGATIVE?- CLICK HEREEUROPEAN EARNINGS: BETTER BUT STILL MIXED - MORGAN STANLEY - CLICK HEREUK GILTS: TRUSSED UP?- CLICK HEREEUROPEAN SHARES BOUNCE, STILL SET FOR WEEKLY FALL - CLICK HEREEUROPE BEFORE THE BELL: FUTURES STEADY BEFORE JOBS DATA - CLICK HEREA NOVEMBER TO R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241101:nL1N3M80VK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061474705.USD","BK4579","LU0889565916.HKD","LU0708995401.HKD","IE00BVYPNV92.GBP","LU0306807586.USD","BK4585","IE0004086264.USD","LU2360032135.SGD","BK4592","IE00B7KXQ091.USD","JNJ","BIIB","LU0080751232.USD","IE0004091025.USD","LU0109391861.USD","LU1035775433.USD","BK4566","LU0882574055.USD","BK4588","BMY","LU1221951129.SGD","IE00BJT1NW94.SGD","LU0072462426.USD","LU1074936037.SGD","LU1430594728.SGD","LU0203347892.USD","LU0471298777.SGD","LU0238689110.USD","LU0237698245.USD","NMRA","IE00B1XK9C88.USD","LU0058720904.USD","LU0792757196.USD","LU1670711123.USD","LU0471298694.HKD","IE00B775H168.HKD","IE00BWXC8680.SGD","AMZN","IE00BSNM7G36.USD","LU1066053197.SGD","IE00B775SV38.USD","CRVO","LU0289739699.SGD","LU0320765646.SGD","LU0345769631.USD","LLY","BK4139","IE00BJTD4N35.SGD","LU0225284248.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":115,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"NMRA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.4,"defaultRemindTime":1747080000000,"name":null,"time":"Post Market","dateTimestamp":1747022400000,"actualEps":null},{"market":"US","date":"2024-11-12","symbol":"NMRA","fiscalQuarterEnding":"2024/09","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.5556,"sell":0.1111,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5556,"analysts":9,"updateTime":1743566400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2025-04-29","current":-0.50597,"percent":0.960317,"low":-19.620035,"twenty":-12.279982,"median":-6.898905,"eighty":-1.320222,"high":-0.41859,"avg":-7.884911,"sd":5.021329,"marketCap":123348965},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-04-29","current":-0.50597,"twenty":-12.279982,"median":-6.898905,"eighty":-1.320222,"marketCap":123348965}],"updateTime":1746086020632}}}